A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
BioXcel Therapeutics Inc
BioXcel Therapeutics Inc
EpicentRx, Inc.
Advaxis, Inc.
Boehringer Ingelheim
Sunesis Pharmaceuticals
Valerio Therapeutics
Valerio Therapeutics
Bayer
Astellas Pharma Inc
Eli Lilly and Company